BackSCP & CO Healthcare Acquisition Co - Warrants (27/10/2025) Overview
SCP & CO Healthcare Acquisition Co - Warrants (27/10/2025)

SCP & CO Healthcare Acquisition Co - Warrants (27/10/2025) Return on Equity

Latest ROE for SCP & CO Healthcare Acquisition Co - Warrants (27/10/2025): 7.97% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

7.97%

Return on Equity

7.97%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

SCP & CO Healthcare Acquisition Co - Warrants (27/10/2025) (SHACW) FAQ

The latest ROE for SHACW is 7.97%. That is above the sector sector average of -5.93%. Investors often review this figure alongside SCP & CO Healthcare Acquisition Co - Warrants (27/10/2025)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SHACW currently prints 7.97% for ROE, while the sector average sits near -5.93%. That is roughly 234.4% above the sector mean. Large gaps often invite a closer look at SCP & CO Healthcare Acquisition Co - Warrants (27/10/2025)'s growth, margins, and balance sheet.

Return on Equity shows how effectively SCP & CO Healthcare Acquisition Co - Warrants (27/10/2025) converts resources into returns. At 7.97%, SHACW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SHACW's ROE (7.97%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.